Results 31 to 40 of about 18,946 (139)

Sirt1 Activity in PBMCs as a Biomarker of Different Heart Failure Phenotypes

Biomolecules, 2020
Heart Failure (HF) is a syndrome, which implies the existence of different phenotypes. The new categorization includes patients with preserved ejection fraction (HFpEF), mid-range EF (HFmrEF), and reduced EF (HFrEF) but the molecular mechanisms involved ...
Valeria Conti, Graziamaria Corbi, Maria Vincenza Polito, Michele Ciccarelli, Valentina Manzo, Martina Torsiello, Emanuela De Bellis, Federica D’Auria, Gennaro Vitulano, Federico Piscione, Albino Carrizzo, Paola Di Pietro, Carmine Vecchione, Nicola Ferrara, Amelia Filippelli   +14 more
doaj   +1 more source

Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON‐HF trial

ESC Heart Failure, 2022
Aims In the heart failure (HF) with preserved ejection fraction (HFpEF) PARAGON‐HF trial, sacubitril/valsartan vs. valsartan improved mortality/morbidity in patients with left ventricular ejection fraction (LVEF) below median (57%).
Lars H. Lund, Gianluigi Savarese, Ashwin Venkateshvaran, Lina Benson, Anna Lundberg, Erwan Donal, Jean‐Claude Daubert, Emmanuel Oger, Cecilia Linde, Camilla Hage   +9 more
doaj   +1 more source

Is heart failure with mid range ejection fraction (HFmrEF) a distinct clinical entity or an overlap group? [PDF]

Int J Cardiol Heart Vasc, 2018
Background: The new category of heart failure (HF), Heart Failure with mid range Ejection Fraction (HFmrEF) has recently been proposed with recent publications reporting that HFmrEF represents a transitional phase.
Webb J, Draper J, Fovargue L, Sieniewicz B, Gould J, Claridge S, Barton C, Smith S, Tondel K, Rajani R, Kapetanakis S, Rinaldi CA, McDonagh TA, Razavi R, Carr-White G.   +14 more
europepmc   +2 more sources

Impact of diastolic dysfunction on outcome in heart failure patients with mid‐range or reduced ejection fraction

ESC Heart Failure, 2021
Aims The role of diastolic dysfunction (DD) in prognostic evaluation in heart failure (HF) patients with impaired systolic function remains unclear.
Dan Liu, Kai Hu, Kolja Lau, Tobias Kiwitz, Katharina Robitzkat, Clara Hammel, Björn Daniel Lengenfelder, Georg Ertl, Stefan Frantz, Peter Nordbeck   +9 more
doaj   +1 more source

Are HFpEF and HFmrEF So Different? The Need to Understand Distinct Phenotypes

Frontiers in Cardiovascular Medicine, 2021
Traditionally, patients with heart failure (HF) are divided according to ejection fraction (EF) threshold more or <50%. In 2016, the ESC guidelines introduced a new subgroup of HF patients including those subjects with EF ranging between 40 and 49 ...
Alberto Palazzuoli, Matteo Beltrami
doaj   +1 more source

HEART FAILURE WITH MID-RANGE LEFT VENTRICULAR EJECTION FRACTION

Wiadomości Lekarskie, 2020
The aim of the publication was to review available data on epidemiology, pathophysiological and clinical aspects of HFmrEF as a specific HF pattern. Materials and methods: We carried out the analysis of the publications that appeared during last decade, related to the different aspects of HFmrEF. The literature search was conducted by use of Google Web
Оlga А, Yepanchintseva, Оleg J, Zharinov, Кyrylo О, Mikhaliev   +2 more
openaire   +2 more sources

Understanding Heart Failure With Mid-Range Ejection Fraction

JACC: Heart Failure, 2016
Heart failure (HF) with borderline or mid-range ejection fraction (HFmEF; 40% ≤EF 
Carolyn S P, Lam, Tiew-Hwa Katherine, Teng   +1 more
openaire   +2 more sources

Particularities of Older Patients with Obstructive Sleep Apnea and Heart Failure with Mid-Range Ejection Fraction. [PDF]

Medicina (Kaunas), 2019
Background and objectives: Obstructive sleep apnea syndrome (OSAS) and heart failure (HF) are increasing in prevalence with a greater impact on the health system.
Ardelean CL, Pescariu S, Lighezan DF, Pleava R, Ursoniu S, Nadasan V, Mihaicuta S.   +6 more
europepmc   +2 more sources

The Value of IGF-1 and IGFBP-1 in Patients With Heart Failure With Reduced, Mid-range, and Preserved Ejection Fraction

Frontiers in Cardiovascular Medicine, 2022
BackgroundPrevious studies have reported inconsistent results regarding the implications of deranged insulin-like growth factor 1 (IGF-1)/insulin-like growth factor-binding protein 1 (IGFBP-1) axis in patients with heart failure (HF).
Shaohua Guo, Mengqi Gong, Gary Tse, Gary Tse, Gary Tse, Guangping Li, Kang-Yin Chen, Tong Liu   +7 more
doaj   +1 more source

ST2 in heart failure with reduced and mid-range ejection fraction: clinical and instrumental relationships and prognostic value

Наука и инновации в медицине, 2021
Objectives to determine the clinical and instrumental relationships and prognostic value of sST2 in chronic heart failure with reduced and mid-range ejection fraction of ischemic etiology. Material and methods.
Natalya V. Kompanets, Olesya Yu. Aidumova, Yurii V. Shchukin   +2 more
doaj   +1 more source